Letter by Cardinale et al Regarding Article, "Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial".
Daniela Maria CardinaleAlexander Richard LyonTeresa López FernándezPublished in: Circulation (2024)
Keyphrases
- study protocol
- randomized controlled trial
- angiotensin converting enzyme
- healthcare
- palliative care
- angiotensin ii
- clinical trial
- phase iii
- left ventricular
- quality improvement
- phase ii
- double blind
- cross sectional
- pain management
- open label
- stem cells
- heart failure
- affordable care act
- mesenchymal stem cells
- binding protein
- chronic pain